|
1
|
Chang HJ, Yoo BC, Kim SW, et al:
Significance of PML and p53 protein as molecular prognostic markers
of gallbladder carcinomas. Pathol Oncol Res. 13:326–335. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jiang WX, Song BG and Wang PJ: Expression
of nm23, KAI1 and spiral computed tomography findings in primary
gallbladder carcinoma. Chin Med J (Engl). 122:2666–2668.
2009.PubMed/NCBI
|
|
3
|
Marshall JC, Collins JW, Nakayama J, et
al: Effect of inhibition of the lysophosphatidic acid receptor 1 on
metastasis and metastatic dormancy in breast cancer. J Natl Cancer
Inst. 104:1306–1319. 2012.PubMed/NCBI
|
|
4
|
Boissan M, De Wever O, Lizarraga F, et al:
Implication of metastasis suppressor NM23-H1 in maintaining
adherens junctions and limiting the invasive potential of human
cancer cells. Cancer Res. 70:7710–7722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu HK, Wang Q, Li Y, et al: Inhibitory
effects of gamma-tocotrienol on invasion and metastasis of human
gastric adenocarcinoma SGC-7901 cells. J Nutr Biochem. 21:206–213.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Niitsu N, Hayama M, Yoshino T, et al:
Multicentre phase II study of the CyclOBEAP regimen for patients
with peripheral T-cell lymphoma with analysis of biomarkers. Br J
Haematol. 153:582–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niitsu N, Nakamine H, Okamoto M, et al;
Adult Lymphoma Treatment Study Group, ALTSG. Expression of nm23-H1
is associated with poor prognosis in peripheral T-cell lymphoma. Br
J Haematol. 123:621–630. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Magyarosy E, Sebestyén A and Timár J:
Expression of metastasis associated proteins, CD44v6 and nm23-H1,
in pediatric acute lymphoblastic leukemia. Anticancer Res.
21:819–823. 2001.
|
|
9
|
Bozkurt S, Uz B, Buyukasik Y, et al:
Prognostic importance of additional cytogenetic anomalies in
chronic myeloid leukemia. Med Oncol. 30:4432013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Piccaluga PP, Paolini S, Bertuzzi C, et
al: First-line treatment of chronic myeloid leukemia with
nilotinib: critical evaluation. J Blood Med. 3:151–156. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sawyers CL: The 2011 Gordon Wilson
lecture: overcoming resistance to targeted cancer drugs. Trans Am
Clin Climatol Assoc. 123:114–125. 2012.PubMed/NCBI
|
|
12
|
Bircan S, Inamdar KV, Rassidakis GZ and
Medeiros LJ: nm23-H1 expression in non-Hodgkin and Hodgkin
lymphomas. Appl Immunohistochem Mol Morphol. 16:207–214. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Niitsu N, Honma Y, Iijima K, et al:
Clinical significance of nm23-H1 proteins expressed on cell surface
in non-Hodgkin's lymphoma. Leukemia. 17:196–202. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lilly AJ, Khanim FL, Hayden RE, et al:
Nm23-H1 indirectly promotes the survival of acute myeloid leukemia
blast cells by binding to more mature components of the leukemic
clone. Cancer Res. 71:1177–1186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bach E, Krahl R, Lange T, et al: Delayed
processing of bone marrow samples reveals a prognostic pattern of
NME mRNA expression in cytogenetically normal acute myeloid
leukemia. Leuk Lymphoma. 53:1561–1568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin L, Liu G, Zhang CH, et al: Nm23-H1
regulates the proliferation and differentiation of the human
chronic myeloid leukemia K562 cell line: a functional proteomics
study. Life Sci. 84:458–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Boissan M and Lacombe ML: NM23, an example
of a metastasis suppressor gene. Bull Cancer. 99:431–440. 2012.(In
French).
|
|
18
|
Conery AR, Sever S and Harlow E:
Nucleoside diphosphate kinase Nm23-H1 regulates chromosomal
stability by activating the GTPase dynamin during cytokinesis. Proc
Natl Acad Sci USA. 107:15461–15466. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao XS, Song PL, Sun B, et al: Arsenic
trioxide inhibits metastatic potential of mouse hepatoma H22 cells
in vitro and in vivo. Hepatobiliary Pancreat Dis Int. 8:510–517.
2009.PubMed/NCBI
|
|
20
|
Okabe-Kado J, Kasukabe T, Honma Y, et al:
Extracellular NM23-H1 protein inhibits the survival of primary
cultured normal human peripheral blood mononuclear cells and
activates the cytokine production. Int J Hematol. 90:143–152. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tschiedel S, Gentilini C, Lange T, et al:
Identification of NM23-H2 as a tumour-associated antigen in chronic
myeloid leukaemia. Leukemia. 22:1542–1550. 2008. View Article : Google Scholar : PubMed/NCBI
|
